DossierENTITY

immune system diseases

Coverage of immune system diseases in the Nexus archive.

Earliest in view: Aug 5 · 01:06 UTCMost recent: Aug 5 · 01:06 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSAug 5 · 01:06 UTCBLOOMBERG
Goldman-Backed Biotech Attovia Raises $289 Million in US IPO
Attovia Therapeutics Inc., a biotech firm developing treatments for immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range. Goldman Sachs backed the company during its IPO.